Case Name: ROCHE PALO ALTO LLC, Plaintiff-Appellant, v. RANBAXY LABORATORIES LIMITED and Ranbaxy, Inc., Defendants-Cross Appellants
Court: United States Court of Appeals for the Federal Circuit
Jurisdiction: United States
Decision Date: 2010-08-24
Citations: 455 F. App'x 963
Docket Number: Nos. 2010-1056, 2010-1101
Parties: ROCHE PALO ALTO LLC, Plaintiff-Appellant, v. RANBAXY LABORATORIES LIMITED and Ranbaxy, Inc., Defendants-Cross Appellants.
Judges: 
Reporter: West's Federal Appendix
Volume: 455
Pages: 963–963

Head Matter:
ROCHE PALO ALTO LLC, Plaintiff-Appellant, v. RANBAXY LABORATORIES LIMITED and Ranbaxy, Inc., Defendants-Cross Appellants.
Nos. 2010-1056, 2010-1101.
United States Court of Appeals, Federal Circuit.
Aug. 24, 2010.

Opinion:
ON MOTION
ORDER
Upon consideration of the parties' joint motion to remand this ease, Roche Palo Alto LLC v. Ranbaxy Laboratories Limited and Ranbaxy. Inc., to the United States District Court for the District of New Jersey, case no. 06-CV-2003, for further proceedings consistent with the settlement agreement reached by the parties, and specifically to allow the District Court to consider granting the parties' motion for vacatur,
IT IS ORDERED THAT:
(1) The motion is granted.
(2) Each side shall bear its own costs.